news
Longevity gets a nonprofit research center in NYC
Deerfield Managing Partner Jim Flynn is funding a new nonprofit longevity research center in New York City, aiming to cut through the industry's hype. He views 'longevity' itself as a misnomer, emphasizing the need for robust data and clear 'error bars' in research.
Deerfield Managing Partner Jim Flynn is funding a new nonprofit longevity research center in New York City, aiming to cut through the industry's hype. He views 'longevity' itself as a misnomer, emphasizing the need for robust data and clear 'error bars' in research.
The architecture take
I appreciate the skepticism. Someone finally said it: if you're going to talk about extending lifespans and healthspans, you better have the receipts. This new nonprofit center isn't just another clinic; it's a direct challenge to the often-fuzzy claims in the longevity space, pushing for hardcore data over aspirational marketing. Flynn's point about 'error bars' is critical – I think most of us want to know how solid the science is, especially when we're talking about expensive interventions designed to tweak things like our metabolism or cellular repair pathways.
It's a necessary counter-movement against what feels like an endless stream of celebrity-backed supplements and unproven biohacks. This move from a serious investor suggests a coming correction in how longevity science is funded and evaluated. The next step, I hope, is more direct comparison trials on actual human biomarkers, not just animal models or proxy measures. It’s simple: show me what it does to my blood sugar, my sleep architecture, my immune response. Then we can talk.